Senti Biosciences Inc (SNTI) Stock Price, Quote & News

Company Profile

Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. The company's product candidates also include SENTI-202, a logic gated off-the-shelf...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 239 2030

Website: www.sentibio.com

Address:

2 Corporate Drive, First Floor, South San Francisco, United States

YasirTrades Jul. 5 at 9:18 PM

SSY is quietly setting up for something major. Ultra low float. No dilution. Trading under $1 with a massive merger catalyst in play. These types of setups don’t stay quiet forever when the trigger hits, they move fast and hard. Perfect storm brewing for those paying attention. $APRN $TIO $NUWE $SNTI

0 · Reply

Waldorfoster Jun. 25 at 4:21 PM

$SNTI Anyone catch the investor’s meeting?

0 · Reply

EricTheMidgetLynch Jun. 24 at 8:01 PM

$SNTI this company dumps shares at the very last second in the market and post market every single day. I've watched it for a week and it never fails they drive the price down with less than one min

0 · Reply

R3N4RD Jun. 24 at 3:12 PM

$SNTI That drop was ridiculous, it's about to bounce back.

0 · Reply

YasirTrades Jun. 23 at 2:12 PM

GLMD: $1 stock with $12+ book, $20M+ cash, no dilution, and a GLP-1 catalyst any week now. Last run hit $24. This is what a pressure cooker looks like before it blows. $PHGE $TTOO $SNTI $MBOT ..

0 · Reply

EricTheMidgetLynch Jun. 23 at 1:53 PM

$SNTI they have destroyed shareholder confidence. what a big piece of trash. Puts out good news. Drops below 2 bucks. Stock was at 3.84 on 6/6. It's amazing how it can be brought down on such little volume.

1 · Reply

YasirTrades Jun. 23 at 1:42 PM

GLMD could be the most asymmetric biotech setup of the year. Sitting near $1 with $20M+ cash, no toxic dilution, and a definitive GLP-1 agreement due within weeks. Book value near $12, ran to $24 last cycle, and now floating under radar. When catalysts hit, there may not be time to chase. Get in before the crowd does. #biotech #GLP1 #smallcaps $GLMD $TTOO $HOTH $SNTI

1 · Reply

Waldorfoster Jun. 22 at 3:45 PM

$SNTI $SENTI Bioscience 🌱the future is abundant🌱✊believe the science✌️🌈FDA positive news🌈💪🏽PT $15💪🏽🌸take notice🌸🚀entry point🚀🌕Moooon shot🌘@SENTI BIOSCIENCES #curecancer #Medical science news $SPDR® S&P 500® ETF $NASDAQ $AMC Entmt Hldgs Inc $GAMESTOP Corp

1 · Reply

_www_larval_com_ Jun. 20 at 7:52 PM

$SRM -6%[30%] $SNTI 4%[-1%] $ZYBT 4%[14%] $GALT -4%[-25%] $DFDV 3%[-21%] most notable movement into the final minutes of trading.

0 · Reply

adelyn_low6 Jun. 20 at 6:12 PM

$SNTI

0 · Reply

Senti Bio Participates in Nasdaq Amplify Spotlight Series

Jun 24, 2025, 8:45 AM EDT - 12 days ago

Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference

Jun 18, 2025, 7:00 AM EDT - 19 days ago

Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia

Jun 9, 2025, 4:30 PM EDT - 27 days ago

Senti Biosciences Announces New Employment Inducement Grants

Jun 6, 2025, 9:05 AM EDT - 4 weeks ago

Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC

May 30, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Senti Biosciences, Inc. (SNTI) Shareholders to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Senti Biosciences, Inc. (SNTI) And Encourages Shareholders to Connect

May 28, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Senti Biosciences, Inc. (SNTI) And Encourages Shareholders to Reach Out

May 27, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Senti Biosciences, Inc. (SNTI) and Encourages Shareholders to Learn More About the Investigation

May 26, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Senti Biosciences, Inc. (SNTI) and Encourages Investors to Learn More About the Investigation

May 25, 2025, 10:00 AM EDT - 6 weeks ago

Senti Biosciences, Inc. (SNTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 23, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Senti Biosciences, Inc. (SNTI) And Encourages Investors to Connect

May 22, 2025, 4:05 PM EDT - 6 weeks ago

Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

May 22, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Senti Biosciences, Inc. (SNTI) Stockholders to Inquire about Securities Investigation

May 22, 2025, 8:30 AM EDT - 6 weeks ago

Senti Bio Receives Additional $1.0 Million Tranche from California Institute for Regenerative Medicines (CIRM) Grant for Advancing Clinical Development of SENTI-202

May 21, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Senti Biosciences, Inc. (SNTI) Investors to Inquire about Securities Investigation

May 20, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Senti Biosciences, Inc. (SNTI) And Encourages Investors to Reach Out

May 20, 2025, 5:28 AM EDT - 6 weeks ago

SNTI Investors Have Opportunity to Join Senti Biosciences, Inc. Fraud Investigation with the Schall Law Firm

May 19, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Senti Biosciences, Inc. (SNTI) And Encourages Stockholders to Reach Out

May 18, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Senti Biosciences, Inc. (SNTI) And Encourages Stockholders to Connect

May 16, 2025, 2:00 PM EDT - 7 weeks ago

Senti Biosciences, Inc. (SNTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 8, 2025, 8:35 AM EDT - 2 months ago

Senti Bio Releases Mechanism of Action Video for First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202

May 6, 2025, 4:35 PM EDT - 2 months ago

Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development

May 1, 2025, 9:15 AM EDT - 2 months ago

Senti Bio Releases Virtual Investor “What This Means” Segment

Apr 30, 2025, 9:00 AM EDT - 2 months ago

Senti Bio to Present at the Citizens JMP Life Sciences Conference

$Senti Bio's SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML$

Apr 28, 2025, 7:00 AM EDT - 2 months ago

Senti Bio's SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML

Apr 24, 2025, 8:35 AM EDT - 2 months ago

Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 on Monday, April 28th at 8:30 AM ET

Apr 21, 2025, 9:05 AM EDT - 2 months ago

Senti Bio Participates in a Virtual Investor KOL Connect Segment

Apr 16, 2025, 9:15 AM EDT - 2 months ago

Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment

Apr 10, 2025, 8:45 AM EDT - 3 months ago

Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.

Apr 7, 2025, 8:45 AM EDT - 3 months ago

Senti Bio Joins Webull Corporate Connect Service Platform

Apr 3, 2025, 9:00 AM EDT - 3 months ago

Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025

Mar 20, 2025, 4:01 PM EDT - 3 months ago

Senti Bio Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Pipeline and Corporate Highlights

Mar 13, 2025, 4:01 PM EDT - 4 months ago

Senti Bio Appoints Feng Hsiung to Board of Directors

Feb 25, 2025, 8:00 AM EST - 4 months ago

Senti Bio Strengthens Leadership Team with Strategic Hires

YasirTrades Jul. 5 at 9:18 PM

0 · Reply

Waldorfoster Jun. 25 at 4:21 PM

$SNTI Anyone catch the investor’s meeting?

0 · Reply

EricTheMidgetLynch Jun. 24 at 8:01 PM

$SNTI this company dumps shares at the very last second in the market and post market every single day. I've watched it for a week and it never fails they drive the price down with less than one min

0 · Reply

R3N4RD Jun. 24 at 3:12 PM

$SNTI That drop was ridiculous, it's about to bounce back.

0 · Reply

YasirTrades Jun. 23 at 2:12 PM

GLMD: $1 stock with $12+ book, $20M+ cash, no dilution, and a GLP-1 catalyst any week now. Last run hit $24. This is what a pressure cooker looks like before it blows. $PHGE $TTOO $SNTI $MBOT ..

0 · Reply

EricTheMidgetLynch Jun. 23 at 1:53 PM

1 · Reply

YasirTrades Jun. 23 at 1:42 PM

1 · Reply

Waldorfoster Jun. 22 at 3:45 PM

1 · Reply

_www_larval_com_ Jun. 20 at 7:52 PM

$SRM -6%[30%] $SNTI 4%[-1%] $ZYBT 4%[14%] $GALT -4%[-25%] $DFDV 3%[-21%] most notable movement into the final minutes of trading.

0 · Reply

adelyn_low6 Jun. 20 at 6:12 PM

$SNTI

0 · Reply

Waldorfoster Jun. 20 at 1:08 PM

$SNTI https://www.timothysykes.com/news/senti-biosciences-inc-snti-news-2025_06_18/

0 · Reply

WallStreetStocksNStuff Jun. 20 at 12:00 PM

$SNTI can the tide roll

0 · Reply

Waldorfoster Jun. 19 at 11:23 PM

$SNTI Will Friday bring recovery? Or more pain?

1 · Reply

Ned_Nosurname Jun. 19 at 12:06 AM

$SNTI https://www.globenewswire.com/news-release/2025/6/18/3101311/0/en/Senti-Bio-Granted-U-S-FDA-Orphan-Drug-Designation-for-Use-of-First-in-Class-Off-the-Shelf-Logic-Gated-Selective-CD33-OR-FLT3-NOT-EMCN-CAR-NK-Cell-Therapy-SENTI-202-to-Treat-Acute-M.html

0 · Reply

AbhiSg Jun. 18 at 11:21 PM

$SNTI any reason which be seen that's making this stock go this much down ?

3 · Reply

BOOOOOLIISHH Jun. 18 at 10:18 PM

$SNTI Damn it I don't know what made me trade this trash it's just something about these letters I do not like and I threw money in this crap anyway. Sometimes you know tickers that suck subconsciously from the past so I don't know why I even tried this crap

0 · Reply

BOOOOOLIISHH Jun. 18 at 10:16 PM

$SNTI Is this done man what the fuck

0 · Reply

Olivia_Strickland Jun. 18 at 8:01 PM

$SNTI wow what a scumbag company. Every single time they've put out news they also drop tons of shares. Why to kill a company. This stock is going on my do not trade list/short only list.

3 · Reply

XDoeDoeDrumsX Jun. 18 at 4:36 PM

$SNTI wow this stock sucks balls lol

1 · Reply

Trader1141 Jun. 18 at 4:35 PM

$SNTI fck this market… lol Started a short! No bulls here 😎

1 · Reply

dust6431 Jun. 18 at 2:47 PM

$SNTI

0 · Reply

Omnitrader69 Jun. 18 at 2:43 PM

$SNTI Surprised this is down...are we expecting an offering? Not familiar w company really but news seemed good.

1 · Reply

Market Cap	57.38M
Revenue (ttm)	0.00
Net Income (ttm)	-52.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	113,800
Avg Vol	250,772
Day's Range	N/A - N/A
Shares Out	26.08M
Stochastic %K	67%
Beta	2.09
Analysts	Strong Sell
Price Target	$12.00